GKOS Glaukos Corporation
Healthcare$120.23-13.52%ClosedMarket Cap: $7.06B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
10.40
P/S
12.81
EV/EBITDA
-176.56
DCF Value
$-61.49
FCF Yield
-0.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
78.1%
Operating Margin
-15.6%
Net Margin
-34.3%
ROE
-26.5%
ROA
-21.2%
ROIC
-10.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $150.6M | 77.9% | $-19.9M | $-19.8M | $— | — |
| Q4 null | $143.1M | 77.8% | $-27.0M | $-133.7M | $— | — |
| FY null | $507.4M | 77.5% | $-86.7M | $-187.7M | $— | — |
| Q3 null | $133.5M | 78.4% | $-16.4M | $-16.2M | $— | — |
| Q2 null | $124.1M | 78.3% | $-22.7M | $-19.7M | $— | — |
| Q1 null | $106.7M | 77.2% | $-20.7M | $-18.1M | $— | — |
| Q4 null | $105.5M | 72.9% | $-28.7M | $-33.6M | $— | — |
| FY null | $383.5M | 75.5% | $-122.4M | $-146.4M | $— | — |
| Q3 null | $96.7M | 76.6% | $-24.7M | $-21.4M | $— | — |
| Q2 null | $95.7M | 76.4% | $-30.0M | $-50.5M | $— | — |
| Q1 null | $85.6M | 76.3% | $-39.1M | $-40.8M | $— | — |
| Q4 2023 | $82.4M | 77.1% | $-38.6M | $-36.8M | $-0.75 | — |